| Year |
Citation |
Score |
| 2017 |
Merling RK, Kuhns DB, Sweeney CL, Wu X, Burkett S, Chu J, Lee J, Koontz S, Di Pasquale G, Afione SA, Chiorini JA, Kang EM, Choi U, De Ravin SS, Malech HL. Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease. Blood Advances. 1: 270-278. PMID 29296942 DOI: 10.1182/Bloodadvances.2016001214 |
0.325 |
|
| 2017 |
Chu J, Smelkinson MG, Dorward DW, Zarember KA, Gallin JI. Early intracellular trafficking of Granulibacter bethesdensis in human macrophages. Infection and Immunity. PMID 28320834 DOI: 10.1128/Iai.00847-16 |
0.326 |
|
| 2015 |
Kuhns DB, Priel DA, Chu J, Zarember KA. Isolation and Functional Analysis of Human Neutrophils. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. 111: 7.23.1-7.23.16. PMID 26528633 DOI: 10.1002/0471142735.Im0723S111 |
0.319 |
|
| 2015 |
Greenberg DE, Sturdevant DE, Marshall-Batty KR, Chu J, Pettinato AM, Virtaneva K, Lane J, Geller BL, Porcella SF, Gallin JI, Holland SM, Zarember KA. Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease. Infection and Immunity. 83: 4277-92. PMID 26283340 DOI: 10.1128/Iai.00778-15 |
0.324 |
|
| 2015 |
Merling RK, Sweeney CL, Chu J, Bodansky A, Choi U, Priel DL, Kuhns DB, Wang H, Vasilevsky S, De Ravin SS, Winkler T, Dunbar CE, Zou J, Zarember KA, Gallin JI, et al. An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 147-57. PMID 25288370 DOI: 10.1038/Mt.2014.195 |
0.339 |
|
| 2015 |
Ravin SSD, Li L, Choi U, Chu J, Theobald N, Koontz S, Lee J, Zarember K, Khuu H, Cantilena C, Peshwa MV, Malech HL. 298. Transfection of Neutrophils from X-Linked Chronic Granulomatous Disease Patients with gp91phox mRNA Restores Oxidase Activity with High Efficiency and Viability Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33907-7 |
0.35 |
|
| 2013 |
Chu J, Song HH, Zarember KA, Mills TA, Gallin JI. Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase. Journal of Immunology (Baltimore, Md. : 1950). 191: 3297-307. PMID 23956436 DOI: 10.4049/Jimmunol.1300200 |
0.345 |
|
| 2013 |
Merling RK, Sweeney CL, Choi U, Bodansky A, Chu J, Priel DL, Kuhns DB, Wang H, Vasilevsky S, Winkler T, DeRavin SS, Zou J, Leto T, Dunbar CE, Gallin J, et al. A Platform Minigene AAVS1 Targeted Safe Harbor Approach For Genetic Correction Of iPSC Derived From Patients With Each Of The 5 Genetic Forms Of Chronic Granulomatous Disease Blood. 122: 1024-1024. DOI: 10.1182/Blood.V122.21.1024.1024 |
0.366 |
|
| 2012 |
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, et al. Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen. Infection and Immunity. 80: 975-81. PMID 22184421 DOI: 10.1128/Iai.05557-11 |
0.31 |
|
| 2010 |
Sun C, Chu J, Singh S, Salter RD. Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function. Purinergic Signalling. 6: 31-45. PMID 19838818 DOI: 10.1007/S11302-009-9168-9 |
0.502 |
|
| 2009 |
Chu J, Thomas LM, Watkins SC, Franchi L, Núñez G, Salter RD. Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. Journal of Leukocyte Biology. 86: 1227-38. PMID 19675207 DOI: 10.1189/Jlb.0309164 |
0.462 |
|
| Show low-probability matches. |